SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on September 30, 2008. The filing reports the consolidated financial results for the fiscal year 2009 first quarter ended August 31, 2008. The report incorporates a press release (Exhibit 99.1) by reference.
Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION". The summary below reflects the content of the provided filing text.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release. It does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibit 99.1 (Press Release), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended August 31, 2008.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These elements are presumed to be in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Exhibit 99.1 press release.
- Confirm the company name discrepancy between the request metadata (Lifecore Biomedical) and the filing (Landec Corporation).
- Review the press release for any guidance or outlook statements not present in this 8-K summary.
- Check for any material changes in financial condition detailed in the full press release.